Lawrence B. Cohen’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,170
| Closed | -$2.21M | – | 37 |
|
|
2023
Q3 | $2.21M | Buy |
28,170
+241
| +0.9% | +$20.2K | 1.49% | 35 |
|
|
2023
Q2 | $2.46M | Sell |
27,929
-130
| -0.5% | -$11.2K | 1.58% | 26 |
|
|
2023
Q1 | $2.26M | Buy |
28,059
+2,250
| +9% | +$183K | 1.52% | 30 |
|
|
2022
Q4 | $2.01M | Buy |
25,809
+307
| +1% | +$24.9K | 1.05% | 42 |
|
|
2022
Q3 | $2.06M | Sell |
25,502
-494
| -2% | -$44.4K | 1.59% | 22 |
|
|
2022
Q2 | $2.33M | Buy |
25,996
+624
| +2% | +$63.2K | 1.66% | 24 |
|
|
2022
Q1 | $2.81M | Buy |
25,372
+1,402
| +6% | +$148K | 1.67% | 26 |
|
|
2021
Q4 | $2.48M | Sell |
23,970
-1,445
| -6% | -$167K | 0.97% | 42 |
|
|
2021
Q3 | $3.19M | Sell |
25,415
-2,457
| -9% | -$318K | 1.68% | 23 |
|
|
2021
Q2 | $3.46M | Sell |
27,872
-700
| -2% | -$87.9K | 1.76% | 24 |
|
|
2021
Q1 | $3.38M | Sell |
28,572
-323
| -1% | -$37.9K | 1.83% | 23 |
|
|
2020
Q4 | $3.38M | Sell |
28,895
-1,126
| -4% | -$124K | 1.88% | 20 |
|
|
2020
Q3 | $3.12M | Buy |
30,021
+473
| +2% | +$47.5K | 1.9% | 18 |
|
|
2020
Q2 | $2.71M | Buy |
29,548
+410
| +1% | +$39.3K | 1.81% | 21 |
|
|
2020
Q1 | $2.63M | Sell |
29,138
-641
| -2% | -$68.2K | 2.06% | 17 |
|
|
2019
Q4 | $3.38M | Buy |
29,779
+667
| +2% | +$73.2K | 1.99% | 20 |
|
|
2019
Q3 | $3.16M | Sell |
29,112
-1,544
| -5% | -$161K | 2.07% | 19 |
|
|
2019
Q2 | $2.98M | Sell |
30,656
-455
| -1% | -$41.5K | 2.07% | 19 |
|
|
2019
Q1 | $2.83M | Sell |
31,111
-2,253
| -7% | -$202K | 1.99% | 24 |
|
|
2018
Q4 | $3.04M | Buy |
33,364
+429
| +1% | +$40.1K | 2.36% | 18 |
|
|
2018
Q3 | $3.24M | Sell |
32,935
-1,993
| -6% | -$184K | 2.2% | 20 |
|
|
2018
Q2 | $2.99M | Sell |
34,928
-4,974
| -12% | -$415K | 2.14% | 21 |
|
|
2018
Q1 | $3.2M | Sell |
39,902
-1,390
| -3% | -$115K | 2.15% | 23 |
|
|
2017
Q4 | $3.33M | Sell |
41,292
-30
| -0.1% | -$2.4K | 2.11% | 22 |
|
|
2017
Q3 | $3.21M | Sell |
41,322
-730
| -2% | -$60.6K | 2.09% | 23 |
|
|
2017
Q2 | $3.73M | Sell |
42,052
-10,962
| -21% | -$924K | 2.39% | 18 |
|
|
2017
Q1 | $4.27M | Sell |
53,014
-2,247
| -4% | -$176K | 2.63% | 16 |
|
|
2016
Q4 | $3.94M | Sell |
55,261
-3,480
| -6% | -$273K | 2.39% | 17 |
|
|
2016
Q3 | $5.08M | Sell |
58,741
-1,460
| -2% | -$127K | 3.02% | 11 |
|
|
2016
Q2 | $5.22M | Sell |
60,201
-6,773
| -10% | -$548K | 3.13% | 9 |
|
|
2016
Q1 | $5.02M | Sell |
66,974
-1,000
| -1% | -$75.3K | 3.29% | 9 |
|
|
2015
Q4 | $5.23M | Sell |
67,974
-5,260
| -7% | -$396K | 3.55% | 8 |
|
|
2015
Q3 | $4.9M | Sell |
73,234
-651
| -0.9% | -$47.9K | 3.41% | 7 |
|
|
2015
Q2 | $5.47M | Sell |
73,885
-1,509
| -2% | -$115K | 3.46% | 8 |
|
|
2015
Q1 | $5.88M | Sell |
75,394
-618
| -0.8% | -$46.8K | 3.59% | 8 |
|
|
2014
Q4 | $5.49M | Buy |
76,012
+3,288
| +5% | +$228K | 3.3% | 9 |
|
|
2014
Q3 | $4.5M | Buy |
72,724
+1,075
| +2% | +$68.3K | 2.97% | 13 |
|
|
2014
Q2 | $4.57M | Sell |
71,649
-230
| -0.3% | -$14K | 3% | 12 |
|
|
2014
Q1 | $4.42M | Sell |
71,879
-921
| -1% | -$53.6K | 3.06% | 13 |
|
|
2013
Q4 | $4.18M | Sell |
72,800
-2,500
| -3% | -$142K | 2.98% | 15 |
|
|
2013
Q3 | $4.01M | Sell |
75,300
-7,500
| -9% | -$404K | 3.04% | 13 |
|
|
2013
Q2 | $4.26M | Buy |
+82,800
| New | +$4.09M | 3.14% | 10 |
|
Other funds holding MDT
Lawrence B. Cohen's MDT Position: Q4 2023 in Review
Lawrence B. Cohen sold out of Medtronic (MDT) in Q4 2023, closing a stake of 28,170 shares — an estimated $2.21M sold.
Lawrence B. Cohen first reported a position in MDT in Q2 2013 and held it in 42 quarters. The position peaked at $5.88M in Q1 2015. 2,075 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- Lawrence B. Cohen reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
- Lawrence B. Cohen sold 28,170 Medtronic shares in Q4 2023, an estimated $2.21M.
- Lawrence B. Cohen first reported a position in Medtronic in Q2 2013 and held it in 42 quarters.
- Lawrence B. Cohen's Medtronic position peaked at $5.88M in Q1 2015.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.